AstraZeneca wins shareholder approval for New York listing

AstraZeneca wins shareholder approval for New York listing

Move by FTSE’s biggest company gains support of 99% of shareholders who voted in blow to London market

Leave a Reply

Your email address will not be published. Required fields are marked *

Page Reader Press Enter to Read Page Content Out Loud Press Enter to Pause or Restart Reading Page Content Out Loud Press Enter to Stop Reading Page Content Out Loud Screen Reader Support
WordPress Cookie Plugin by Real Cookie Banner